Renee P Tannenbaum - Net Worth and Insider Trading
Renee P Tannenbaum Net Worth
The estimated net worth of Renee P Tannenbaum is at least $2 Million dollars as of 2024-12-28. Renee P Tannenbaum is the Director of ANI Pharmaceuticals Inc and owns about 18,211 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $990,861. Renee P Tannenbaum is the Director of Zogenix Inc and owns about 32,567 shares of Zogenix Inc (ZGNX) stock worth over $868,888. Renee P Tannenbaum is also the Director of Sharps Compliance Corp and owns about 18,436 shares of Sharps Compliance Corp (SMED) stock worth over $161,315. Besides these, Renee P Tannenbaum also holds Cardiff Oncology Inc (CRDF) . Details can be seen in Renee P Tannenbaum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Renee P Tannenbaum has not made any transactions after 2024-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Renee P Tannenbaum
Renee P Tannenbaum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Renee P Tannenbaum owns 4 companies in total, including Zogenix Inc (ZGNX) , Sharps Compliance Corp (SMED) , and ANI Pharmaceuticals Inc (ANIP) among others .
Click here to see the complete history of Renee P Tannenbaum’s form 4 insider trades.
Insider Ownership Summary of Renee P Tannenbaum
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ZGNX | Zogenix Inc | 2021-11-29 | director |
SMED | Sharps Compliance Corp | 2012-03-16 | director |
ANIP | ANI Pharmaceuticals Inc | 2024-05-16 | director |
2024-12-12 | director |
Renee P Tannenbaum Latest Holdings Summary
Renee P Tannenbaum currently owns a total of 4 stocks. Among these stocks, Renee P Tannenbaum owns 18,211 shares of ANI Pharmaceuticals Inc (ANIP) as of May 16, 2024, with a value of $990,861 and a weighting of 47.02%. Renee P Tannenbaum owns 32,567 shares of Zogenix Inc (ZGNX) as of November 29, 2021, with a value of $868,888 and a weighting of 41.23%. Renee P Tannenbaum also owns 18,436 shares of Sharps Compliance Corp (SMED) as of March 16, 2012, with a value of $161,315 and a weighting of 7.65%. The other 1 stocks Cardiff Oncology Inc (CRDF) have a combined weighting of 4.1% among all his current holdings.
Latest Holdings of Renee P Tannenbaum
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ANIP | ANI Pharmaceuticals Inc | 2024-05-16 | 18,211 | 54.41 | 990,861 |
ZGNX | Zogenix Inc | 2021-11-29 | 32,567 | 26.68 | 868,888 |
SMED | Sharps Compliance Corp | 2012-03-16 | 18,436 | 8.75 | 161,315 |
CRDF | Cardiff Oncology Inc | 2024-12-12 | 20,000 | 4.32 | 86,400 |
Holding Weightings of Renee P Tannenbaum
Renee P Tannenbaum Form 4 Trading Tracker
According to the SEC Form 4 filings, Renee P Tannenbaum has made a total of 1 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 2,000 shares on May 16, 2024, which brought Renee P Tannenbaum around $127,740.
According to the SEC Form 4 filings, Renee P Tannenbaum has made a total of 2 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zogenix Inc is the sale of 5,305 shares on November 29, 2021, which brought Renee P Tannenbaum around $62,175.
According to the SEC Form 4 filings, Renee P Tannenbaum has made a total of 0 transactions in Sharps Compliance Corp (SMED) over the past 5 years. The most-recent trade in Sharps Compliance Corp is the acquisition of 10,000 shares on March 16, 2012, which cost Renee P Tannenbaum around $38,400.
More details on Renee P Tannenbaum's insider transactions can be found in the Insider Trading History of Renee P Tannenbaum table.Insider Trading History of Renee P Tannenbaum
- 1
Renee P Tannenbaum Trading Performance
GuruFocus tracks the stock performance after each of Renee P Tannenbaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renee P Tannenbaum is -8.52%. GuruFocus also compares Renee P Tannenbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renee P Tannenbaum within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Renee P Tannenbaum's insider trading performs compared to the benchmark.
Performance of Renee P Tannenbaum
Renee P Tannenbaum Ownership Network
Renee P Tannenbaum Owned Company Details
What does Zogenix Inc do?
Who are the key executives at Zogenix Inc?
Renee P Tannenbaum is the director of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .
Zogenix Inc (ZGNX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zogenix Inc Insider Transactions
Renee P Tannenbaum Mailing Address
Above is the net worth, insider trading, and ownership report for Renee P Tannenbaum. You might contact Renee P Tannenbaum via mailing address: 9220 Kirby Drive, Suite 500, Houston Tx 77054.